| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
GROWTH FACTORS-CYTOKINES-ONCOGENES |
Department of Internal Medicine (G.J., K.N., B.W., S.W., K.H.), Division of Hematology/Oncology, Philipps-University, Baldingerstrasse, D-35033 Marburg, Germany; Molecular Concepts Research (MCR) (R.T.R.), Munich, Germany; and I.M. Setchenow Medical Academy (E.K.), Moscow
Address all correspondence and requests for reprints to: Gabriele Jacques, Klinikum de Philipps-Universitat, Zentrum fur Innere Medizin, Baldinger Strasse, Marburg, 35043 Germany.
Considerable evidence exists that lung cancer cell lines produce large amounts of insulin-like growth factor-binding proteins (IGFBPs). In addition, these cells are subject to an autocrine or paracrine growth control by insulin-like growth factors (IGFs). We now demonstrate by immunocytochemistry with IGFBP-3 antibodies that nuclei of a lung cancer cell line distinctly immunostain for IGFBP-3. This finding led us to investigate in more detail the localization of this protein that, to date, had only been known to occur extracellularly. Ligand blotting revealed that purified nuclear extracts contain a 43,000-Da IGFBP which can bind [I125]IGF-I. By Western blot this protein was identified as IGFBP-3. Thus, our data are consistent with the results of a previous structural study predicting a nuclear localization for IGFBP-3. Moreover, our findings raise the possibility that nuclear IGFBP-3 is functional and involved in the pathogenesis of lung cancer.
This article has been cited by other articles:
![]() |
W. R. Dayton and M. E. White Cellular and molecular regulation of muscle growth and development in meat animals J Anim Sci, April 1, 2008; 86(14_suppl): E217 - E225. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Kaplan and P. Cohen REVIEW: The Somatomedin Hypothesis 2007: 50 Years Later J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4529 - 4535. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Schedlich, A. Muthukaruppan, M. K. O'Han, and R. C. Baxter Insulin-Like Growth Factor Binding Protein-5 Interacts with the Vitamin D Receptor and Modulates the Vitamin D Response in Osteoblasts Mol. Endocrinol., October 1, 2007; 21(10): 2378 - 2390. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus J. Biol. Chem., August 25, 2006; 281(34): 24588 - 24601. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhao, P. Yin, L. A. Bach, and C. Duan Several Acidic Amino Acids in the N-domain of Insulin-like Growth Factor-binding Protein-5 Are Important for Its Transactivation Activity J. Biol. Chem., May 19, 2006; 281(20): 14184 - 14191. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Oufattole, S. W.-J. Lin, B. Liu, D. Mascarenhas, P. Cohen, and B. D. Rodgers Ribonucleic Acid Polymerase II Binding Subunit 3 (Rpb3), a Potential Nuclear Target of Insulin-Like Growth Factor Binding Protein-3 Endocrinology, May 1, 2006; 147(5): 2138 - 2146. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. R. Santer, N. Bacher, B. Moser, D. Morandell, S. Ressler, S. M. Firth, G. A. Spoden, C. Sergi, R. C. Baxter, P. Jansen-Durr, et al. Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis. Cancer Res., March 15, 2006; 66(6): 3024 - 3033. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Y. Chan, S. M. Twigg, S. M. Firth, and R. C. Baxter Insulin-Like Growth Factor Binding Protein-3 Leads to Insulin Resistance in Adipocytes J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6588 - 6595. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Li, J. Xiang, and C. Duan Insulin-like Growth Factor-binding Protein-3 Plays an Important Role in Regulating Pharyngeal Skeleton and Inner Ear Formation and Differentiation J. Biol. Chem., February 4, 2005; 280(5): 3613 - 3620. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-W. Lee, B. Liu, L. Ma, H. Li, P. Bang, H. P. Koeffler, and P. Cohen Cellular Internalization of Insulin-like Growth Factor Binding Protein-3: DISTINCT ENDOCYTIC PATHWAYS FACILITATE RE-UPTAKE AND NUCLEAR LOCALIZATION J. Biol. Chem., January 2, 2004; 279(1): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems Endocr. Rev., December 1, 2003; 24(6): 737 - 764. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Schedlich, T. Nilsen, A. P. John, D. A. Jans, and R. C. Baxter Phosphorylation of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid-Dependent Protein Kinase Reduces Ligand Binding and Enhances Nuclear Accumulation Endocrinology, May 1, 2003; 144(5): 1984 - 1993. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Martin, S. M. Weenink, and R. C. Baxter Insulin-like Growth Factor-binding Protein-3 Potentiates Epidermal Growth Factor Action in MCF-10A Mammary Epithelial Cells. INVOLVEMENT OF p44/42 AND p38 MITOGEN-ACTIVATED PROTEIN KINASES J. Biol. Chem., January 24, 2003; 278(5): 2969 - 2976. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Spoerri, S. Caballero, S. H. Wilson, L. C. Shaw, and M. B. Grant Expression of IGFBP-3 by Human Retinal Endothelial Cell Cultures: IGFBP-3 Involvement in Growth Inhibition and Apoptosis Invest. Ophthalmol. Vis. Sci., January 1, 2003; 44(1): 365 - 369. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Firth and R. C. Baxter Cellular Actions of the Insulin-Like Growth Factor Binding Proteins Endocr. Rev., December 1, 2002; 23(6): 824 - 854. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Chang, K. Gong, S. Sun, D. Liu, A. K. El-Naggar, F. R. Khuri, W. K. Hong, and H.-Y. Lee Clinical Significance of Insulin-like Growth Factor-binding Protein-3 Expression in Stage I Non-Small Cell Lung Cancer Clin. Cancer Res., December 1, 2002; 8(12): 3796 - 3802. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Wright, J. M.P. Holly, R. Galea, M. Brincat, and H. D. Mason Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-4 on Human Granulosa Cell Steroidogenesis Biol Reprod, September 1, 2002; 67(3): 776 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Butt, K. A. Fraley, S. M. Firth, and R. C. Baxter IGF-Binding Protein-3-Induced Growth Inhibition and Apoptosis Do Not Require Cell Surface Binding and Nuclear Translocation in Human Breast Cancer Cells Endocrinology, July 1, 2002; 143(7): 2693 - 2699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hong, G. Zhang, F. Dong, and M. M. Rechler Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells J. Biol. Chem., March 15, 2002; 277(12): 10489 - 10497. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Booth, M. Boes, B. L. Dake, K. L. Knudtson, and R. S. Bar IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis Am J Physiol Endocrinol Metab, January 1, 2002; 282(1): E52 - E58. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. R. Clemmons Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships Endocr. Rev., December 1, 2001; 22(6): 800 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Wilson, Y. Oh, V. Hwa, and R. G. Rosenfeld Interaction of IGF-Binding Protein-Related Protein 1 with a Novel Protein, Neuroendocrine Differentiation Factor, Results in Neuroendocrine Differentiation of Prostate Cancer Cells J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4504 - 4511. [Abstract] [Full Text] [PDF] |
||||
![]() |
R C Baxter Signalling pathways involved in antiproliferative effects of IGFBP-3: a review Mol. Pathol., June 1, 2001; 54(3): 145 - 148. [Abstract] [Full Text] |
||||
![]() |
S. A. Weinzimer, T. B. Gibson, P. F. Collett-Solberg, A. Khare, B. Liu, and P. Cohen Transferrin Is an Insulin-Like Growth Factor-Binding Protein-3 Binding Protein J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1806 - 1813. [Abstract] [Full Text] |
||||
![]() |
K. C. Pozios, J. Ding, B. Degger, Z. Upton, and C. Duan IGFs stimulate zebrafish cell proliferation by activating MAP kinase and PI3-kinase-signaling pathways Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2001; 280(4): R1230 - R1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Hwa, Y. Oh, and R. G. Rosenfeld The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily Endocr. Rev., December 1, 1999; 20(6): 761 - 787. [Abstract] [Full Text] |
||||
![]() |
M. van Kleffens, C. A. H. Groffen, N. F. J. Dits, D. J. Lindenbergh-Kortleve, A. G. P. Schuller, S. L. Bradshaw, J. E. Pintar, E. C. Zwarthoff, S. L. S. Drop, and J. W. van Neck Generation of Antisera to Mouse Insulin-Like Growth Factor Binding Proteins (IGFBP)-1 to -6: Comparison of IGFBP Protein and Messenger Ribonucleic Acid Localization in the Mouse Embryo Endocrinology, December 1, 1999; 140(12): 5944 - 5952. [Abstract] [Full Text] |
||||
![]() |
Y. Shang, C. R. Baumrucker, and M. H. Green Signal Relay by Retinoic Acid Receptors alpha and beta in the Retinoic Acid-induced Expression of Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells J. Biol. Chem., June 18, 1999; 274(25): 18005 - 18010. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Sprenger, S. E. Damon, V. Hwa, R. G. Rosenfeld, and S. R. Plymate Insulin-like Growth Factor Binding Protein-related Protein 1 (IGFBP-rP1) Is a Potential Tumor Suppressor Protein for Prostate Cancer Cancer Res., May 1, 1999; 59(10): 2370 - 2375. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yu, M. R. Spitz, J. Mistry, J. Gu, W. K. Hong, and X. Wu Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis J Natl Cancer Inst, January 20, 1999; 91(2): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Schedlich, T. F. Young, S. M. Firth, and R. C. Baxter Insulin-like Growth Factor-binding Protein (IGFBP)-3 and IGFBP-5 Share a Common Nuclear Transport Pathway in T47D Human Breast Carcinoma Cells J. Biol. Chem., July 17, 1998; 273(29): 18347 - 18352. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nabeyrat, V. Besnard, S. Corroyer, V. Cazals, and A. Clement Retinoic acid-induced proliferation of lung alveolar epithelial cells: relation with the IGF system Am J Physiol Lung Cell Mol Physiol, July 1, 1998; 275(1): L71 - L79. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rajaram, D. J. Baylink, and S. Mohan Insulin-Like Growth Factor-Binding Proteins in Serum and Other Biological Fluids: Regulation and Functions Endocr. Rev., December 1, 1997; 18(6): 801 - 831. [Abstract] [Full Text] |
||||
![]() |
M. M. Rechler Editorial: Growth Inhibition by Insulin-Like Growth Factor (IGF) Binding Protein-3--What's IGF Got To Do with It? Endocrinology, July 1, 1997; 138(7): 2645 - 2647. [Full Text] [PDF] |
||||
![]() |
L. J. Schedlich, S. L. Le Page, S. M. Firth, L. J. Briggs, D. A. Jans, and R. C. Baxter Nuclear Import of Insulin-like Growth Factor-binding Protein-3 and -5 Is Mediated by the Importin beta Subunit J. Biol. Chem., July 28, 2000; 275(31): 23462 - 23470. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liu, H.-Y. Lee, S. A. Weinzimer, D. R. Powell, J. L. Clifford, J. M. Kurie, and P. Cohen Direct Functional Interactions between Insulin-like Growth Factor-binding Protein-3 and Retinoid X Receptor-alpha Regulate Transcriptional Signaling and Apoptosis J. Biol. Chem., October 20, 2000; 275(43): 33607 - 33613. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |